News Column

CHINA BIOLOGIC PRODUCTS, INC. FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders

June 23, 2014



Item 5.07 Submission of Matters to a Vote of Security Holders.

China Biologic Products, Inc. (the "Company") held its 2014 Annual Meeting of Stockholders (the "Annual Meeting") on Friday, June 20, 2014. Proxies for the Annual Meeting were solicited pursuant to the Company's amended proxy statement filed on May 19, 2014 with the Securities and Exchange Commission under Section 14(a) of the Securities Exchange Act of 1934 (the "Amended Proxy Statement").

The Company's stockholders considered five proposals, each of which is described in the Amended Proxy Statement. A total of 17,892,112 shares were represented in person or by proxy, or 76.40% of the total shares outstanding as of April 22, 2014, the record date of the Annual Meeting. The final results of votes with respect to the proposals submitted for stockholder vote at the Annual Meeting are set forth below.

Proposal 1 - Election of directors

Stockholders elected Sean Shao, Wenfang Liu and David Hui Li as Class II directors for a three-year term as follows:

Director For Withhold Sean Shao 17,639,191 252,921 Wenfang Liu 17,695,634 196,478 David Hui Li 17,891,558 554



Proposal 2 - Ratification of the selection of KPMG as the Company's independent public accounting firm for the fiscal year ending December 31, 2014

Stockholders ratified the selection of KPMG as the Company's independent public accounting firm for the fiscal year ending December 31, 2014.

For Against Abstain 17,891,842 270 -



Proposal 3 - Advisory vote on executive compensation

Stockholders approved the compensation of our named executive officers as disclosed in the Amended Proxy Statement.

For Against Abstain 17,886,858 2,254 3,000



Proposal 4 - Adoption of amendment to the Company's certificate of incorporation and bylaws to clarify that the term of a director chosen by other directors to fill a vacancy on the Company's board of directors will coincide with the term of the class to which such director has been elected

Stockholders approved the adoption of an amendment to Clause (c) of EIGHTH Article of the Company's certificate of incorporation and Section 3.04 of the Company's bylaws as disclosed in the Amended Proxy Statement to clarify that the term of a director chosen by other directors to fill a vacancy on the Company's board of directors will coincide with the term of the class to which such director has been elected.

For Against Abstain 17,794,236 97,776 100



Proposal 5 - Adoption of amendment to the Company's bylaws to authorize stockholders holding 25% of the entire capital stock of the Company issued and outstanding and entitled to vote to call a special meeting of the stockholders

Stockholders approved the adoption of an amendment to Section 2.03 of the Company's bylaws as disclosed in the Amended Proxy Statement to authorize stockholders holding 25% of the entire capital stock of the Company issued and outstanding and entitled to vote to call a special meeting of the stockholders.

For Against Abstain 17,638,758 253,154 200



There were no broker non-votes for any of the proposals submitted for stockholder vote at the Annual Meeting.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters